InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: Phoenix300 post# 322496

Monday, 09/07/2020 11:16:06 PM

Monday, September 07, 2020 11:16:06 PM

Post# of 402940
As it says in the press release. Brilacidin for treatment of unmentionable ailments with unpronounceable names was licensed to Alfasigma. A trial was supposed to commence mid-2020, but is probably on hold due to another ailment going on globally.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News